Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001171843-26-002302
- form_type
- 8-K
- ticker
- CRMT
- cik
- 0000799850
- company_name
- AMERICAS CARMART INC
- filed_at
- 2026-04-07T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.747390+00:00
- generated_at
- 2026-05-15T07:11:31.515015+00:00
- sec_items
- ["2.05", "2.06", "7.01", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.9
- calibrated_materiality_score
- 0.9
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001171843-26-002302
- json_url
- https://secwatch.observer/filing/0001171843-26-002302.json
- markdown_url
- https://secwatch.observer/filing/0001171843-26-002302.md
- text_url
- https://secwatch.observer/filing/0001171843-26-002302.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/799850/000117184326002302/0001171843-26-002302-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/799850/000117184326002302/f8k_040726.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
KOP
Koppers conditionally plans to shut Stickney, IL chemical operations; Q1 adjusted EPS down 19.7%
Koppers Holdings Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 2.02, 2.05, 5.02, 5.07, 7.01, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
potentially appropriate uses for the Stickney facility following the end of production activities. The Company expects this action to result in pre-tax charges to earnings of $227 million to $262 million through the end of 2029, approximately $170 million to $195 million of which constitutes non-cash charges and approximately $57 million to $67 million of which
Filing page
SEC filing
NET
Cloudflare Q1 revenue $639.8M +34% YoY; announces 20% workforce reduction
Cloudflare, Inc.
May 7, 2026, 7:59 PM ET
other_material
Items 2.02, 2.05, 7.01, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
On May 7, 2026, the Company announced a plan (the “Plan”) designed to further accelerate its evolution to an agentic AI-first operating model. As part of the Plan, the Company expects to reduce its current workforce by approximately 20%. The Company currently estimates that it will incur charges of between $140 million and $150 million in connection with the Plan
Filing page
SEC filing
SNAP
Snap reports Q1 rev ~$1.53B (+12% YoY), adj EBITDA ~$233M; cuts 16% of staff (~1,000 jobs)
Snap Inc
April 15, 2026, 7:59 PM ET
other_material
Items 2.02, 2.05, 7.01, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
increased operational efficiencies to accelerate our path toward net-income profitability. As a result, we currently estimate that we will incur pre-tax charges in the range of $95 million to $130 million, primarily consisting of severance and related costs, contract termination costs, and other impairment charges, of which $75 million to $100 million are expected
Filing page
SEC filing
TEAM
Atlassian to cut ~10% workforce (~1,600 roles); CTO Rajeev Rajan departing
Atlassian Corp
March 11, 2026, 7:59 PM ET
other_material
Items 2.05, 7.01, 5.02, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
efficiency and sustainability. Position eliminations in each country are subject to local law and consultation requirements. The Company estimates it will incur approximately $225 million to $236 million in charges in connection with these actions, of which approximately $169 million to $174 million is expected to result in future cash outlays related to
Filing page
SEC filing
INM
InMed to wind down BayMedica commercial ops; focus shifts to Alzheimer's, AMD pipeline
InMed Pharmaceuticals Inc.
March 6, 2026, 6:59 PM ET
other_material
Items 2.05, 7.01, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
In connection with the wind down of commercial operations, BayMedica is expected to incur severance and other employee-related costs of approximately $550,000 and expects to incur additional related expenditures of approximately $120,000 through the end of the fiscal year.
Filing page
SEC filing
TBPH
Theravance Biopharma Phase 3 CYPRESS study fails; plans 50% workforce cut and strategic review
Theravance Biopharma, Inc.
March 3, 2026, 6:59 PM ET
other_material
Items 2.02, 2.05, 7.01, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.
Filing page
SEC filing
BCAB
BioAtla initiates strategic review, cuts 70% workforce; CFO replaced; cash ~$7.1M
BioAtla, Inc.
March 2, 2026, 6:59 PM ET
other_material
Items 2.02, 7.01, 2.05, 5.02, 8.01, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
formal process to explore and evaluate strategic options to maximize
shareholder value. The total cash payments related to this
workforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company
expects to pay for the majority of these costs in the first quarter of 2026. The estimates of the
Filing page
SEC filing
ADSK
Autodesk to cut ~1,000 jobs (7% workforce) as GTM transformation final phase; Q4 guidance raised above top end
Autodesk, Inc.
January 22, 2026, 6:59 PM ET
other_material
Items 2.05, 7.01, 9.01
same fact type: restructuring_charge
same SEC item: 2.05, 7.01, 9.01
same event type: other_material
similar materiality
This filing
the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.
Comparable filing
key strategic priorities across the Company throughout its fiscal year ending January 31, 2027. The Company expects to incur total pre-tax restructuring charges of approximately $135 million to $160 million, which is primarily attributable to employee termination benefits, in connection with the Plan. Substantially all of the pre-tax restructuring charges will result
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.